Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N- methyl-N-nitrosourea

Prostate

Volumn 35, Issue 4, 1998, Pages 255-262

  Okamoto, Masato ^a   Webber, Mukta M ^b   Quader, Salmaan ^b   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Anchorage indepen dence; Androgen; EGF; Human prostatic epithelial cell lines; IL 6

Indexed keywords

ANDROGEN; ANDROSTANOLONE; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; METHYLNITROSOUREA;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR CELL LINE;

CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-6; KINETICS; MALE; METHYLNITROSOUREA; PROSTATE; RECEPTORS, INTERLEUKIN-6; TIME FACTORS;

EID: 0032102901     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980601)35:4<255::AID-PROS4>3.0.CO;2-F     Document Type: Article

References (24)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. Silverberg E, Boring CC, Squires TS: Cancer statistics, 1990. CA Cancer J Clin 1990;40:9-26.
3. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS: Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 1996;17:1641-1646.
4. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS: Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997;18:1215-1223.
5. Webber MM, Bello D, Quader S: Immortalized and tumorigenic adult human prostatic epithelial cell lines. Characteristics and applications. Part 1. Cell markers and immortalized, nontumorigenic cell lines. Prostate 1996;29:386-394.
6. Webber MM, Bello D, Quader S: Immortalized and tumorigenic adult human prostatic epithelial cell lines. Characteristics and applications. Part 2. Tumorigenic cell lines. Prostate 1997;30:58-64.
7. Webber MM, Bello D, Quader S: Immortalized and tumorigenic adult human prostatic epithelial cell lines. Characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications. Prostate 1997;30:136-142.
8. Chen L, Mory Y, Zilberstein A, Revel M: Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2. Proc Natl Acad Sci USA 1988;85: 8037-8041.
9. Eustace D, Han X, Gooding R, Rowbottom A, Riches P, Heyderman E: Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol 1993;50: 15-19.
10. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T: Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989;250:607-610.
11. Okamoto M, Hattori K, Oyasu R: Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer 1997;72:149-154.
12. Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB: Interleukin-6 immunoreactivity in human tumors. Am J Pathol 1989; 135:427-433.
13. Takenawa J, Kaneko Y, Fukumoto M, Fukatsu A, Hirano T, Fukuyama H, Nakayama H, Fujita J, Yoshida O: Enhanced expression of interleukin-6 in primary human renal carcinomas. J Natl Cancer Inst 1991;83:1668-1672.
14. Okamoto M, Lee C, Oyasu R: Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 1997;57:141-146.
15. Borsellino N, Belldegrun A, Bonavida B: Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res 1995;55:4633-4639.
16. Siegsmund MJ, Yamazaki H, Pastan I: Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J Urol 1994;151:1396-1399.
17. Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I: Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990;50:7786-7788.
18. Lee C: Cellular interactions in prostate cancer. Br J Urol [Suppl] 1997;79:21-27.
19. Davies P, Eaton CL: Regulation of prostate growth. J Endocrinol 1991;131:5-17.
20. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 1987; 47:936-942.
21. Okamoto M, Kawamata H, Kawai K, Oyasu R: Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin 6. Cancer Res 1995;55:4581-4585.
22. Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM: Autonomous growth of androgen-independent human prostatic carcinoma cells: Role of transforming growth factor-α. Cancer Res 1991;51:2780-2785.
23. Twillie DA, Eisenberger MA, Carducci MA, Hseih W, Kim WY, Simons JW: Interleukin-6: A candidate mediator of human prostate cancer morbidity. Urology 1995;45:542-549.
24. Michaelopoulos GK, DeFrances MC: Liver regeneration. Science 1997;276:60-66.